Etoricoxib Hexafluorophosphate Intermediate

The Etoricoxib Hexafluorophosphate Intermediate is a key compound in the synthesis of Etoricoxib, a selective COX-2 inhibitor used to treat pain and inflammation in conditions such as arthritis. The intermediate is likely involved in the formation of the final active pharmaceutical ingredient (API) and is stabilized as a hexafluorophosphate salt for ease of handling or reactivity. About the Company GST Registration Date: May 2020 Legal Status of Firm: Proprietorship Number of Employees: Upto 10 People Annual Turnover: 0 - 40 L company-description: "S M Pharmachem is a manufacturer of Active Pharmaceutical Ingredients (API's), Intermediates. S M Pharmachem was founded and incorporated in 2020 at Shrirampur, with a manufacturing facility located at Shrirampur,Ahmednagar Since inception we have focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Our primary focus has been on Anti-Diabetic Drugs, Anti-Coagulant, Anti-Ulcerative, which is estimated to be one of the fastest growing therapeutic segments.Additionally, we also undertake Toll/Custom Manufacturing for API's and Intermediates on contract basis. with this we are manufacturing products like meta nitro benzaldehyde, meta hydroxy benzaldehyde, gemcitabine T9 intermediate , Allyl formate etc"